Temozolomide Capsule
Product Images NDC 70301-2009

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Temozolomide (NDC 70301-2009). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Opko Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure (Figure)

A Kaplan-Meier survival curve chart displaying overall survival percentages over time in months for patients with newly diagnosed glioblastoma. The chart compares two treatment arms: RT + TMZ (radiation therapy plus Temozolomide) and RT only. The vertical axis represents overall survival percentage, while the horizontal axis shows time in months up to 40 months. A table below the graph indicates the number of patients at risk over time for each treatment group.*

FDA Label Image

Label17 (Label17)

Temozolomide Capsules, USP 180 mg oral capsules packaging label by OPKO Pharmaceuticals, LLC. The carton indicates a hazardous drug with 5 individual sachets, each containing one capsule. Storage instructions specify 25°C with allowable excursions to 15-30°C. The label includes warnings to swallow capsules whole and avoid contact with damaged capsules. The NDC is 70301-2009-1.*

FDA Label Image

Label18 (Label18)

Label for Temozolomide Capsule USP 180 mg by OPKO Pharmaceuticals, LLC. The label includes the drug name, strength (180 mg) in a red box, distributor information at Miami, FL, barcode, lot and expiration dates, and warnings about the drug being hazardous. The label is designed for a capsule package with clear dosing and caution instructions.*

FDA Label Image

Label19 (Label19)

Flat layout of packaging for Temozolomide Capsules, USP, 180 mg strength. The carton displays the product name, dosage form as capsules for oral administration, and a warning that it is a hazardous drug for prescription use only. It contains 14 individual sachets, each with one capsule. The label notes storage conditions, dosage warnings, and distributor information as OPKO Pharmaceuticals, LLC, Miami, FL, with a barcode visible on two panels. The OPKO logo appears on the packaging.*

FDA Label Image

Label20 (Label20)

Label for Temozolomide Capsule, USP 180 mg, an oral capsule distributed by OPKO Pharmaceuticals, LLC. The front label shows the drug name, strength in a red box, distributor information, and a warning about the drug being highly hazardous with instructions to read accompanying directions carefully. The back label includes a barcode and placeholders for lot and expiration date.*

FDA Label Image

Chemical Structure (Temo Structure)

Chemical structure of Temozolomide, showing a bicyclic ring system with nitrogen atoms and functional groups including an amide (CONH2) and a methyl group (CH3) attached to the ring structure.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.